Pediatric Dermatology

The Inaugural Pediatric Dermatology 2020: Best Practices and Innovations Conference is now open for registration and scheduled to take place June 27th, offering seven free CME credits.

The FDA announced it has accepted a priority review of dupilumab for the treatment of moderate-to-severe AD in pediatric patients 6 to 11 years of age. The drug is already approved for treatment of AD in adolescents and adults.

Atopic dermatitis presents differently depending on whether the patient is an adult or child. This means that different treatments may be more effective in an adult than children and vice versa. 

Weight-based dosing of apremilast appeared to ensure comparable efficacy, safety and tolerability with in kids as in adults, and should be explored in future studies.

About one-third of patients with psoriasis are children or adolescents. Still, little research exists on treating this patient population. New disease management guidelines and emerging studies seek to fill the gap.

Crisaborole ointment, 2%, (Eucrisa, Pfizer) appears to be safe and effective in children aged three months to less than 24 months who have mild-to-moderate atopic dermatitis, according to results of a phase 4 trial released yesterday.

Pulsed dye laser (PDL) is widely accepted as the gold standard treatment of port-wine stains (PWS), but how early can you begin treating infants with PWS? According to this expert and a recent study, the sooner the better. 

Traditional treatments remain important parts of the dermatologist's armamentarium for acne management, but other drugs have begun to play a role, too. Meanwhile, research is offering new insight into the causes of acne. Stay up to date on the latest insight into acne's pathogenesis, evaluation and treatment.  Participate in this forum.

When it comes to dietary triggers for acne, the list of supposed villains is long. While absolute proof isn't currently reproducible, one expert says there are several foods that have shown a connection. Participate in this forum.

“Pretty much, I couldn’t go about my normal life,” says Benjamin Sun about a life-altering eczema flare up at age 9, which left him out of school and bedridden for weeks. Until now, children like Sun didn’t have an effective, safe option for long-term disease control. Read how dupilumab changed his quality of life, and what it can do for your pediatric patients with uncontrolled moderate to severe atopic dermatitis.

Caregivers of children with autism often expect dermatologists to have an understanding of the disorder, but that may not always be the case. Learn how to best navigate clinical situations with this patient population in this article.

Mothers of children with atopic dermatitis may be more likely to experience difficulty falling asleep, insufficient sleep and daytime exhaustion, according to a recent study. 

Novel therapeutic recently completed phase three CAMP-1 and CAMP-2 pivotal trials, demonstrating statistically significant improvements in patients with molluscum contagiosum.

Low-dose bleomycin injections used to treat venous and venous lymphatic malformations might have an unanticipated side effect, according to recent research.

Developing psoriasis during childhood or adolescence can affect self-esteem. Dr. Amy Paller discussed the impact of psoriasis on adolescents, and treatment options, during the annual NPR Residents Meeting.

The distribution of localized infantile hemangiomas of the face and scalp favor involvement of the midline face, scalp and ocular axis, shows a retrospective review published in the journal Pediatric Dermatology.

Malformations are as a result of treatment with low-dose bleomycin injections, study shows.

Obesity appears to be an important independent risk factor for children with psoriasis who go on to develop cormorbidities, such as hypertension and diabetes, a study shows.

A summary of treatments for atopic dermatitis in children. 

Physicians spell out knowns and unknowns associated with treating pediatric atopic dermatitis.

 FDA approves early, pre-approval trials for pediatric cases

Oral propranolol may be safe for infants with uncomplicated hemangiomas, but for those with underlying health conditions, it may not always be the treatment of choice.

Pediatric melanomas are often misdiagnosed by physicians. Adolescents have a more aggressive disease course than children and are treated with adult protocols leading to chronic morbidity.

Photos taken by parents and submitted by smartphone are usually of sufficient quality to allow accurate diagnosis of some common pediatric skin conditions, results of a recent study in JAMA Dermatology suggests.

Pediatric dermatologist  Alanna Bree, M.D., left a secure position with a well-respected hospital to embark on a faith-filled professional journey. In this profile, Dr. Bree shares her story of practice, discovery and renewal.

Bronchial hyperreactivity associated with propranolol treatment for infantile hemangiomas may be due to age and low body weight, study shows.

Stress factors mothers experience before, during and soon after pregnancy can increase eczema risk in their children, according to a systematic review published Feb. 25, 2018 in The International Journal of Environmental Research and Public Health.

Pediatricians respond to the first successful gene therapy treatment for epidermolysis bullosa.

A daily capsule of a cocktail of probiotics may reduce both the severity symptoms in moderate atopic dermatitis and the need for topical corticosteroids to treat symptom flare ups in children.